Notice Number: NOT-OD-17-062
Key Dates
Release Date: April 27, 2017
NOT-OD-18-004
NOT-OD-17-119
NOT-OD-17-114
NOT-OD-16-147
NOT-OD-17-043
NOT-OD-18-009
NOT-OD-18-179
NOT-OD-18-212
NOT-DA-23-033
Issued by
National Institutes of Health (NIH)
Purpose
This notice informs the biomedical and health services research communities of changes to grant application form and application guide instructions for due dates on or after January 25, 2018.
Focus of changes:
- Consolidation of human subjects, inclusion enrollment, and clinical trial information previously collected across multiple agency forms
- Expansion and use of discrete form fields for clinical trial information to
- provide the level of information needed for peer review;
- lead applicants through clinical trial information collection requirements;
- present key information to reviewers and agency staff in a consistent format; and
- align with ClinicalTrials.gov (where possible) and position us for future data exchange with ClinicalTrials.gov
- Incorporation of recent Grants.gov changes to R&R Budget and SBIR/STTR Information forms
These changes will be implemented with application form packages identified with a Competition ID of "FORMS-E" and associated application guide instructions. See High-level Summary of Form Changes in FORMS-E Application Packages for a full list of changes.
Effective Date
Applicants must use FORMS-E application packages for due dates on or after January 25, 2018 and must use FORMS-D application packages for due dates on or before January 24, 2018. Applications submitted using the wrong forms for their intended due date will not be reviewed.
Availability of FORMS-E Application Guides
Application guides for FORMS-E application packages will be posted to the How to Apply - Application Guide page no later than October 25, 2017.
Availability of FORMS-E Application Packages
We will begin posting new funding opportunity announcements (FOAs) with FORMS-E application packages on October 25, 2017.
- New FOAs posted before October 25, 2017 with initial due dates on or after January 25, 2018 will be posted without application forms. Application packages will be added to these FOAs by November 10, 2017.
All NIH "parent" announcements that use standard due dates will be expired and reissued with new FOA numbers, FORMS-E application packages and instructions. The FORMS-E parent announcements will be posted no later than 60 days before their standard due date. For a transition period, both FORMS-D and FORMS-E parent announcements will be active. Applicants must choose the announcement with the appropriate application package for their due date (see table below).
All active FOAs with due dates both before and after January 25, 2018 will be updated to add FORMS-E application packages between October 25, 2017 and November 25, 2017. For a transition period, both FORMS-D and FORMS-E application packages will be active. Applicants must choose the appropriate application package for their due date when presented with both FORMS-D and FORMS-E application packages on the same FOA (see table below).
If your due date is |
You must use |
On or before January 24, 2018, including:
|
FORMS-D application package |
On or after January 25, 2018, including:
|
FORMS-E application package |
Additional guide notices for individual FOAs with unique due date considerations will be issued as needed and referenced in the Related Notices section of each FOA.
Form Update Timing for Administrative Supplement, Successor-in-Interest (Type 6) and Change of Institution (Type 7) Parent Announcements
Parent announcements for administrative supplements and post award administrative actions (successor-in-interest and change of institution applications) do not have set due dates and, consequently, will follow a different timeline than other parent announcements.
The FOAs in the table below will be reissued with new FOA numbers, FORMS-E application packages and instructions on January 25, 2018. Applications started on or after January 25, 2018 must use the new FOAs and FORMS-E application packages.
These FOAs will expire on February 25, 2018 giving applicants one month to complete their initiated FORMS-D applications.
FOA# |
FOA Title |
Change of Grantee Organization (Type 7 Parent) |
|
Successor-in-Interest (Type 6 Parent) |
|
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Admin Supp) |
|
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp) |
|
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp) |
Applications Proposing Clinical Trials
As previously announced, all applications involving clinical trials must be submitted to FOAs specifically designed for clinical trials beginning with due dates on or after January 25, 2018 (NOT-OD-16-147, NOT-OD-17-043).
We will take the following steps to accommodate this new policy:
- Issue new clinical trial FOAs with clinical trial-specific review criteria, FORMS-E application packages, and FORMS-E instructions for due dates on or after January 25, 2018
- Add a new "Clinical Trials" item to the table in Section II of all FOAs (just below "Application Types Allowed") which will include one of the following statements:
- Only accepting applications that propose clinical trial(s)
- Only accepting applications that do not propose clinical trials
- Accepting applications that either propose or do not propose clinical trial(s)
- Expire existing (FORMS-D) clinical trial FOAs by January 24, 2018
Resources:
- High-level Summary of Form Changes in FORMS-E Application Packages
- Annotated Form Set for NIH Grant Applications
- Do I Have the Right Form Version For My Application?
- Application Forms, Form Updates, and Choosing the Correct Forms FAQs
Inquiries
Please direct all inquiries to:
NIH Grants Information
Email: [email protected] (preferred method of contact)
Telephone: 301-945-7573
and Human Services (HHS)
